2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship

Designed and synthesized were a series of pyridines substituted at 2, 4, and 6 positions with various 5- or 6-memberd heteroaromatics as antitumor agents. They were evaluated their topoisomerase I and II inhibitory activities along with cytotoxicities against several human cancer cell lines. Among the prepared compounds, 10–20 showed significant topoisomerase I or II inhibitory activities, and 21–26 showed considerable cytotoxicities against several human cancer cell lines. Structure–activity relationship study indicates that 4′-pyridine at 6-position of central pyridine plays a key role in biological activity.

Designed and synthesized were a series of pyridines substituted at 2, 4, and 6 positions with various 5- or 6-membered heteroaromatics as antitumor agents. They were evaluated for their topoisomerase I and II inhibitory activities along with cytotoxicities against several human cancer cell lines. Among the prepared compounds, 10–20 showed significant topoisomerase I or II inhibitory activity, and 21–26 showed considerable cytotoxicities against several human cancer cell lines. Structure–activity relationship study indicates that 4′-pyridine at 6-position of central pyridine plays a key role in biological activity.Figure optionsDownload as PowerPoint slide